Reports for APOTEX INC

Company Name

APOTEX INC

Totals

Shortage reports

3356

Actual shortage: 218 (6%)
Anticipated shortage: 0 (0%)
Avoided shortage: 10 (0%)
Resolved: 3128 (93%)

Discontinuation Reports

359

To be discontinued: 24 (7%)
Discontinued: 335 (93%)
Reversed: 0 (0%)

Late reports

144 (4%)

Overdue reports

61 (25%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-DASATINIB 70MG TABLET Resolved 2022-07-19 2022-08-12 164882
APO-DASATINIB 50MG TABLET Resolved 2022-10-21 2022-12-17 172360
APO-DASATINIB 100MG TABLET Resolved 2022-11-20 2022-12-17 175315
APO-DASATINIB 20MG TABLET Resolved 2022-12-05 2023-03-16 177126
APO-DASATINIB 100MG TABLET Resolved 2020-10-14 2020-11-02 126277
APO-DASATINIB 50MG TABLET Resolved 2021-01-08 2021-03-17 131145
APO-DASATINIB 100MG TABLET Resolved 2021-01-29 2021-03-25 132715
APO-DASATINIB 70MG TABLET Resolved 2021-02-19 2021-03-04 134430
APO-DASATINIB 70MG TABLET Resolved 2024-04-19 2024-06-21 225776
APO-DEFERASIROX 500MG TABLET FOR SUSPENSION Resolved 2017-08-24 2017-09-22 20281
APO-DEFERASIROX 500MG TABLET FOR SUSPENSION Resolved 2018-01-18 2018-02-12 36432
APO-DEFERASIROX 250MG TABLET FOR SUSPENSION Resolved 2024-09-27 2024-12-20 238844
APO-DEFERASIROX 250MG TABLET FOR SUSPENSION Resolved 2020-08-06 2020-11-28 121891
APO-DEFERASIROX 250MG TABLET FOR SUSPENSION Resolved 2020-04-13 2020-05-22 111901
APO-DEFERASIROX 500MG TABLET FOR SUSPENSION Resolved 2020-05-08 2020-05-22 114285
APO-DEFERASIROX 500MG TABLET FOR SUSPENSION Resolved 2020-06-04 2020-07-28 116533
APO-DEFERASIROX 250MG TABLET FOR SUSPENSION Resolved 2018-03-13 2018-07-03 42717
APO-DEFERASIROX 250MG TABLET FOR SUSPENSION Resolved 2023-09-07 2023-09-15 203819
APO-DEFERASIROX 250MG TABLET FOR SUSPENSION Actual shortage 2025-04-10 2025-05-01 254838
APO-DEFERASIROX (TYPE J) 180MG TABLET Resolved 2025-02-13 2025-02-21 250319

Showing 861 to 880 of 3356

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-CIPROFLOX 750MG TABLET Discontinued 2018-09-07 2018-12-28 60388
APO-CITALOPRAM 20MG TABLET Discontinued 2018-09-07 2019-02-13 60393
APO-CLINDAMYCIN 150MG CAPSULE Discontinued 2019-11-11 2019-11-11 98363
APO-CLINDAMYCIN 150MG CAPSULE To be discontinued 2018-09-07 2018-12-28 60396
APO-CLINDAMYCIN 300MG CAPSULE Discontinued 2018-09-07 2019-07-13 60399
APO-CLOBETASOL SPRAY 0.05% SPRAY Discontinued 2022-09-06 2022-09-06 168648
APO-CLONAZEPAM .5MG TABLET Discontinued 2018-09-07 2018-09-15 60402
APO-CYCLOBENZAPRINE 10MG TABLET Discontinued 2018-09-07 2018-09-15 60405
APO-CYCLOSPORINE ORAL SOLUTION Discontinued 2018-09-07 2018-09-15 60408
APO-DICLO 50MG TABLET (ENTERIC-COATED) Discontinued 2019-08-07 2019-08-07 91117
APO-DICLO 50MG TABLET (ENTERIC-COATED) Discontinued 2018-09-07 2019-08-08 60420
APO-DICLO RAPIDE 50 MG TABLETS 50MG TABLET To be discontinued 2018-09-07 2018-11-02 60423
APO-DICLO SR 100MG TABLET (EXTENDED-RELEASE) Discontinued 2017-03-31 2017-03-31 4909
APO-DICLO SR 75MG TABLET (EXTENDED-RELEASE) Discontinued 2017-03-31 2017-03-31 4915
APO-DICLOFENAC OPHTHALMIC 0.1% SOLUTION Discontinued 2018-09-07 2019-02-13 60426
APO-DILTIAZ CD 300MG CAPSULE (CONTROLLED-DELIVERY) Discontinued 2019-02-01 2019-02-02 74366
APO-DILTIAZ TZ 120MG CAPSULE (EXTENDED RELEASE) Discontinued 2017-03-13 2017-03-13 1064
APO-DILTIAZ TZ 180MG CAPSULE (EXTENDED RELEASE) Discontinued 2017-03-13 2017-03-13 1069
APO-DILTIAZ TZ 240MG CAPSULE (EXTENDED RELEASE) Discontinued 2017-03-13 2017-03-13 1072
APO-DILTIAZ TZ 300MG CAPSULE (EXTENDED RELEASE) Discontinued 2017-03-13 2017-03-13 1075

Showing 121 to 140 of 359